USANA Health Sciences, Inc.
USNA
$30.02
$0.521.76%
NYSE
| 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 876.24M | 854.50M | 861.97M | 875.12M | 900.45M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 876.24M | 854.50M | 861.97M | 875.12M | 900.45M |
| Cost of Revenue | 170.59M | 161.21M | 164.98M | 168.25M | 171.24M |
| Gross Profit | 705.65M | 693.29M | 697.00M | 706.87M | 729.21M |
| SG&A Expenses | 648.33M | 626.97M | 614.66M | 622.53M | 638.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 818.92M | 788.18M | 779.64M | 790.78M | 809.55M |
| Operating Income | 57.32M | 66.32M | 82.33M | 84.34M | 90.90M |
| Income Before Tax | 65.98M | 76.35M | 92.53M | 94.46M | 101.06M |
| Income Tax Expenses | 31.17M | 34.29M | 38.19M | 39.37M | 39.12M |
| Earnings from Continuing Operations | 34.81 | 42.06 | 54.34 | 55.08 | 61.94 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 82.00K | -30.00K | -- | -- | -- |
| Net Income | 34.90M | 42.03M | 54.34M | 55.08M | 61.94M |
| EBIT | 57.32M | 66.32M | 82.33M | 84.34M | 90.90M |
| EBITDA | 77.04M | 80.86M | 95.79M | 97.49M | 103.46M |
| EPS Basic | 1.83 | 2.20 | 2.84 | 2.87 | 3.22 |
| Normalized Basic EPS | 2.17 | 2.49 | 3.02 | 3.08 | 3.28 |
| EPS Diluted | 1.81 | 2.18 | 2.83 | 2.86 | 3.21 |
| Normalized Diluted EPS | 2.16 | 2.49 | 3.01 | 3.06 | 3.27 |
| Average Basic Shares Outstanding | 76.30M | 76.43M | 76.58M | 76.75M | 76.99M |
| Average Diluted Shares Outstanding | 76.43M | 76.65M | 76.80M | 77.09M | 77.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |